 patients
treated with CAS (P ¼ .04).203 A 2020 Cochrane Review
also showed the combination end point of periprocedural
death or stroke or ipsilateral stroke during follow-up was
signiﬁcantly lower with CEA.202
Despite the evidence, there is concern regarding
whether data from randomized controlled trials of CAS
can be extrapolated to real-world experience. In general,
physicians who performed